Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
Loading
Debt to Equity Over TimeNormalizing
Percentile Rank50
3Y CAGR+47.6%
5Y CAGR+14.2%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+47.6%/yr
vs -16.4%/yr prior
5Y CAGR
+14.2%/yr
Recent acceleration
Acceleration
+64.0pp
Accelerating
Percentile
P50
Within normal range
vs 5Y Ago
1.9x
Solid growth
Streak
2 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.21 | +95.1% |
| 2024 | 0.11 | +131.9% |
| 2023 | 0.05 | -28.9% |
| 2022 | 0.06 | -32.5% |
| 2021 | 0.10 | -10.7% |
| 2020 | 0.11 | -1.3% |
| 2019 | 0.11 | -17.8% |
| 2018 | 0.13 | -55.7% |
| 2017 | 0.30 | -58.9% |
| 2016 | 0.73 | - |